Abstract: Two in vivo bioassay methods, a rat medium-term liver bioassay and a rat multiorgan bioassay, can be used for detecting carcinogenic or modifying potentials of endocrine active substances (EASs) on endocrine disruption (ED). The first bioassay, the rat mediumterm liver bioassay, is fundamentally based on the two-step hypothesis of liver carcinogenesis; initiation with diethylnitrosamine (DEN, 200 mg/kg b.w., ip) is followed by test chemical administrations during the second stage, in combination with 2/3 partial hepatectomy. It requires only eight weeks for animal experimental treatment and a further few weeks for quantitative analysis of immunohistochemically demonstrated gluthathione-S-transeferase placental form positive hepatic foci. A total of 313 chemicals/substances have already been analyzed, and the efficacy of the system for hepatocarcinogenesis has thereby been well established. This bioassay also provides information concerning dose responses and inhibitory potentials of test chemicals. Several possible EASs, most of them categorized as pesticides, have already been examined in this bioassay, and dose-response studies of nonylphenol, bisphenol A, and styrene have also been tested. Another bioassay, a medium-term, multiorgan bioassay system, using five different chemical carcinogens-DEN, MNU, BBN, DMH, and DHPN-has also been established for rapid detection of not only hepatocarcinogens, but also other organ-targeted carcinogens. These medium-term bioassays are particularly useful and reliable methods for detecting carcinogenic or modifying potentials of low doses of test chemicals, such as EASs, and these methods can be used for the effects of chemical mixtures of EASs.
INTRODUCTION
The risk of carcinogenic or modifying potentials of endocrine active substances (EASs) on endocrine disruption (ED) to humans is of great concern. It is urgently necessary to establish practical and reli-able bioassay methods for detecting carcinogenic and modifying potentials of EASs, which are effective at very low doses. Two in vivo bioassay methods, a rat medium-term liver bioassay and a rat multiorgan bioassay, can be used for detecting those risks from EASs.
RAT MEDIUM-TERM LIVER BIOASSAY FOR CARCINOGENS
Male 6-week-old F344 rats were initially given a single ip injection of diethylnitrosamine (DEN, 200 mg/kg body weight, b.w.) dissolved in saline to initiate hepatocarcinogenesis (Fig. 1) . Two weeks later, animals received test chemicals and were subjected to two-thirds partial hepatectomy (PH) at week 3. The animals were sacrificed for quantitative analysis of glutathione-S-transferase placental form (GST-P) positive liver foci at week 8. Carcinogenic or modifying potentials of test chemicals are scored by comparing the numbers and areas per cm 2 of induced GST-P-positive foci in the livers of test chemical-treated groups with those of corresponding control groups given DEN alone. A positive response is defined as a single increase in the quantitative values of GST-P-positive foci, a negative response is defined as no change or a decrease. The results obtained have been compared with reported Salmonella/microsome and long-term carcinogenicity test findings for the same compounds.
Results of 313 chemicals in the medium-term liver bioassay
Of a total of 313 chemicals examined, 60 out of 65 known hepatocarcinogens (92 %) gave positive results (Table 1) . Five hepatocarcinogens that proved negative all belonged to the peroxizome proliferator group that depresses GST-P expression. Carcinogens targeting organs other than liver gave fewer positive results (10 out of 43, 23 %). One of the 48 chemicals reported as noncarcinogenic was found to be positive in this assay, but this might suggest that the chemical is a liver tumor promoter rather than the finding being a false-positive. Table 2 showed the results of possible EAS compounds, which have already been examined in the bioassay. Most of all chemicals are categorized as pesticides, but some other chemicals, such as hormone-related medicines, have also been examined. Eight chemicals have been showed positive, and two chemicals showed negative in this bioassay. 
Results of possible EASs, which have been tested in the rat medium-term bioassay

CONCLUSIONS
These medium-term liver and multiorgan bioassay systems are very useful tools for detection of not only genotoxic but also nongenotoxic carcinogens. Positive results obtained in a relatively short period closely correlate with the long-term carcinogenicity test. The bioassays are particularly useful and reliable methods for detecting carcinogenic or modifying potentials of low doses of test chemicals, such as EASs, and these methods can also be used for the effects of chemical mixtures of EASs.
